A detailed history of Dimensional Fund Advisors LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,562,183 shares of AGIO stock, worth $87 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,562,183
Previous 2,196,085 28.87%
Holding current value
$87 Million
Previous $94.7 Million 26.7%
% of portfolio
0.02%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$41.19 - $49.72 $26.1 Million - $31.5 Million
-633,902 Reduced 28.87%
1,562,183 $69.4 Million
Q2 2024

Aug 09, 2024

SELL
$27.55 - $48.83 $10.5 Million - $18.7 Million
-382,473 Reduced 14.83%
2,196,085 $94.7 Million
Q1 2024

May 10, 2024

SELL
$21.32 - $34.81 $388,151 - $633,750
-18,206 Reduced 0.7%
2,578,558 $75.4 Million
Q4 2023

Feb 07, 2024

BUY
$19.97 - $24.53 $2.75 Million - $3.38 Million
137,873 Added 5.61%
2,596,764 $57.8 Million
Q3 2023

Nov 09, 2023

BUY
$24.36 - $28.18 $4.75 Million - $5.5 Million
195,073 Added 8.62%
2,458,891 $60.9 Million
Q2 2023

Aug 09, 2023

BUY
$21.38 - $29.19 $3.69 Million - $5.03 Million
172,467 Added 8.25%
2,263,818 $64.1 Million
Q1 2023

May 12, 2023

BUY
$21.74 - $30.93 $9.53 Million - $13.6 Million
438,272 Added 26.51%
2,091,351 $48 Million
Q4 2022

Feb 09, 2023

BUY
$24.81 - $31.52 $4.33 Million - $5.51 Million
174,690 Added 11.82%
1,653,079 $46.4 Million
Q3 2022

Nov 10, 2022

BUY
$19.51 - $34.14 $2.64 Million - $4.62 Million
135,232 Added 10.07%
1,478,389 $41.8 Million
Q2 2022

Aug 12, 2022

BUY
$17.06 - $31.42 $5.67 Million - $10.4 Million
332,541 Added 32.9%
1,343,157 $29.8 Million
Q1 2022

May 13, 2022

BUY
$26.68 - $34.81 $7.61 Million - $9.93 Million
285,215 Added 39.32%
1,010,616 $29.4 Million
Q4 2021

Feb 09, 2022

BUY
$29.58 - $49.78 $5.47 Million - $9.2 Million
184,903 Added 34.21%
725,401 $23.8 Million
Q3 2021

Nov 12, 2021

BUY
$41.92 - $58.18 $10.8 Million - $14.9 Million
256,725 Added 90.47%
540,498 $24.9 Million
Q2 2021

Aug 12, 2021

SELL
$52.06 - $61.27 $334,901 - $394,149
-6,433 Reduced 2.22%
283,773 $15.6 Million
Q1 2021

May 14, 2021

SELL
$44.23 - $57.5 $24,547 - $31,912
-555 Reduced 0.19%
290,206 $15 Million
Q4 2020

Feb 25, 2021

BUY
$33.21 - $46.54 $9.66 Million - $13.5 Million
290,761 New
290,761 $12.6 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.